Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Progesterone and bone: a closer link than previously realized.

Seifert-Klauss V, Schmidmayr M, Hobmaier E, Wimmer T.

Climacteric. 2012 Apr;15 Suppl 1:26-31. doi: 10.3109/13697137.2012.669530. Review.

PMID:
22432813
2.

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.

Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.

Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016.

PMID:
19059524
3.

Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.

Li D, Hitchcock CL, Barr SI, Yu T, Prior JC.

Epidemiol Rev. 2014;36:137-47. doi: 10.1093/epirev/mxt012. Epub 2013 Nov 25. Review.

PMID:
24275546
4.

Spinal bone loss and ovulatory disturbances.

Prior JC, Vigna YM, Schechter MT, Burgess AE.

N Engl J Med. 1990 Nov 1;323(18):1221-7. Erratum in: N Engl J Med 1993 Jun 10;328(23):1724.

5.

Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.

Watts NB, Nolan JC, Brennan JJ, Yang HM; ESTRATAB/Osteoporosis Study Group.

Menopause. 2000 Nov-Dec;7(6):375-82.

PMID:
11127759
6.

Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study.

Greendale GA, Espeland M, Slone S, Marcus R, Barrett-Connor E; PEPI Safety Follow-Up Study (PSFS) Investigators.

Arch Intern Med. 2002 Mar 25;162(6):665-72.

PMID:
11911720
8.

A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.

Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L.

Maturitas. 1995 Feb;21(2):103-13.

PMID:
7752947
9.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
11.

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

Chesnut CH 3rd, Bell NH, Clark GS, Drinkwater BL, English SC, Johnson CC Jr, Notelovitz M, Rosen C, Cain DF, Flessland KA, Mallinak NJ.

Am J Med. 1997 Jan;102(1):29-37.

PMID:
9209198
12.

Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.

Azizi G, Hansen A, Prestwood KM.

Endocr Res. 2003 May;29(2):133-40.

PMID:
12856800
13.
14.

Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.

Milliken LA, Going SB, Houtkooper LB, Flint-Wagner HG, Figueroa A, Metcalfe LL, Blew RM, Sharp SC, Lohman TG.

Calcif Tissue Int. 2003 Apr;72(4):478-84. Epub 2003 Feb 10.

PMID:
12574871
15.

Comparison of the effects of transdermal estrogen, oral estrogen, and oral estrogen-progestogen therapy on bone mineral density in postmenopausal women.

Cetinkaya MB, Kökçü A, Yanik FF, Başoğlu T, Malatyalioglu E, Alper T.

J Bone Miner Metab. 2002;20(1):44-8.

PMID:
11810416
16.
17.

Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.

Prelevic GM, Bartram C, Wood J, Okolo S, Ginsburg J.

Gynecol Endocrinol. 1996 Dec;10(6):413-20.

PMID:
9032569
18.

Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.

Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H, Birkhaeuser MH, Lippuner K.

Maturitas. 2006 Jan 20;53(2):191-200.

PMID:
16368472
19.

Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.

Ongphiphadhanakul B, Piaseu N, Tung SS, Chailurkit L, Rajatanavin R.

Maturitas. 2000 Feb 15;34(2):179-84.

PMID:
10714913
20.

Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.

Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.

Maturitas. 2008 Jan 20;59(1):2-6. Epub 2007 Dec 3.

PMID:
18063490

Supplemental Content

Support Center